Acetylcholinesterase and butyrylcholinesterase — Drug Target
All drugs that target Acetylcholinesterase and butyrylcholinesterase — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Marketed (3)
- Rivastigmine patch · Chung-Ang University Hosptial, Chung-Ang University College of Medicine · Cholinesterase inhibitor · Neurology
Rivastigmine is a cholinesterase inhibitor that increases acetylcholine levels in the brain by blocking the enzyme that breaks it down. - Rivastigmine Patch 9.5 cm2 · University of California, San Francisco · Cholinesterase inhibitor · Neurology
Rivastigmine is a cholinesterase inhibitor that increases acetylcholine levels in the brain by blocking the enzyme that breaks it down. - Exelon (rivastigmine) · Singapore General Hospital · Cholinesterase inhibitor · Neurology
Rivastigmine inhibits acetylcholinesterase and butyrylcholinesterase enzymes, increasing acetylcholine levels in the brain to improve cognitive function in dementia.
Phase 3 pipeline (1)
- Rivastigmine 5 cm^2 transdermal patch · Novartis · Cholinesterase inhibitor · Neurology
Rivastigmine inhibits acetylcholinesterase and butyrylcholinesterase enzymes, increasing acetylcholine levels in the brain to improve cognitive function.